Hisse Senetlerindeki Sıralama
#38624
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the... Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.
Ticaret Poolbeg Pharma PLC (POLB)
B piyasa değeri ile POLB fiyatı
Piyasa Değeri Poolbeg Pharma PLC(POLB)
Piyasa Değeri: $882.99K
August 2026 itibarıyla Poolbeg Pharma PLC şirketinin piyasa değeri $882.99K. Bu, verilerimize göre Poolbeg Pharma PLC şirketini dünyanın en değerli 38624th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Poolbeg Pharma PLC piyasa değeri geçmişi (2021 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında POLB
| POLB’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.453T
|
+617,591,455.16%
|
|
|
|
|
$4.488T
|
+508,308,899.16%
|
|
|
|
|
$4.161T
|
+471,258,491.05%
|
|
|
|
|
$3.698T
|
+418,834,225.10%
|
|
|
|
|
$2.835T
|
+321,121,244.61%
|
